$RFL
Rafael Holdings Inc Stock $rfl

$rfl Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022079292 Filed on December 13, 2022

Income Statement

Concept	2022 Q4	2021 Q4
Revenue	$70.00K	$1.026M
YoY Change	-93.18%	-2.29%
Cost Of Revenue	$249.0K	$835.0K
YoY Change	-70.18%
Gross Profit	-$179.0K	$191.0K
YoY Change	-193.72%
Gross Profit Margin	-255.71%	18.62%
Selling, General & Admin	$3.109M	$12.89M
YoY Change	-75.88%	397.76%
% of Gross Profit		6749.74%
Research & Development	$2.081M	$2.153M
YoY Change	-3.34%	314.04%
% of Gross Profit		1127.23%
Depreciation & Amortization	$22.00K	$382.0K
YoY Change	-94.24%	-13.18%
% of Gross Profit		200.0%
Operating Expenses	$5.190M	$50.71M
YoY Change	-89.77%	1328.45%
Operating Profit	-$5.142M	-$49.54M
YoY Change	-89.62%
Interest Expense		-$11.00K
YoY Change		-101.17%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$5.202M	-$128.8M
YoY Change	-95.96%	8376.05%
Income Tax	$5.000K
% Of Pretax Income
Net Earnings	-$5.207M	-$112.0M
YoY Change	-95.35%	7625.79%
Net Earnings / Revenue	-7438.57%	-10918.52%
Basic Earnings Per Share	$0.07
Diluted Earnings Per Share	$0.07	-$5.912M
COMMON SHARES
Basic Shares Outstanding	23.02M shares	18.95M shares
Diluted Shares Outstanding	23.02M shares	18.95M shares

Balance Sheet

Concept	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$93.19M	$72.39M
YoY Change	28.73%	905.38%
Cash & Equivalents	$22.17M	$72.39M
Short-Term Investments	$71.01M
Other Short-Term Assets	$1.428M	$5.428M
YoY Change	-73.69%	1257.0%
Inventory
Prepaid Expenses
Receivables	$306.0K	$712.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$94.92M	$78.53M
YoY Change	20.88%	857.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.751M	$42.89M
YoY Change	-95.92%	-2.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$4.958M	$5.956M
YoY Change	-16.76%	-92.28%
Other Assets	$11.00K	$1.463M
YoY Change	-99.25%	-8.56%
Total Long-Term Assets	$8.295M	$51.88M
YoY Change	-84.01%	-58.96%
TOTAL ASSETS
Total Short-Term Assets	$94.92M	$78.53M
Total Long-Term Assets	$8.295M	$51.88M
Total Assets	$103.2M	$130.4M
YoY Change	-20.85%	-3.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.394M	$1.197M
YoY Change	16.46%	-0.25%
Accrued Expenses	$1.602M	$1.292M
YoY Change	23.99%	223.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$14.65M
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.206M	$17.26M
YoY Change	-81.43%	225.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$44.00K	$81.00K
YoY Change	-45.68%
Total Long-Term Liabilities	$44.00K	$81.00K
YoY Change	-45.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.206M	$17.26M
Total Long-Term Liabilities	$44.00K	$81.00K
Total Liabilities	$3.250M	$31.67M
YoY Change	-89.74%	66.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$163.9M
YoY Change
Common Stock	$8.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$103.4M	$98.74M
YoY Change
Total Liabilities & Shareholders Equity	$103.2M	$130.4M
YoY Change	-20.85%	-3.12%

Cashflow Statement

Concept	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$5.207M	-$112.0M
YoY Change	-95.35%	7625.79%
Depreciation, Depletion And Amortization	$22.00K	$382.0K
YoY Change	-94.24%	-13.18%
Cash From Operating Activities	-$2.549M	-$6.474M
YoY Change	-60.63%	144.3%
INVESTING ACTIVITIES
Capital Expenditures		-$29.00K
YoY Change		-80.67%
Acquisitions
YoY Change
Other Investing Activities	$13.94M	-$26.88M
YoY Change	-151.88%	-810.98%
Cash From Investing Activities	$13.94M	-$26.90M
YoY Change	-151.83%	-839.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$15.01M	97.91M
YoY Change	-115.33%	244672.5%
NET CHANGE
Cash From Operating Activities	-$2.549M	-6.474M
Cash From Investing Activities	$13.94M	-26.90M
Cash From Financing Activities	-$15.01M	97.91M
Net Change In Cash	-$3.704M	64.53M
YoY Change	-105.74%	6165.15%
FREE CASH FLOW
Cash From Operating Activities	-$2.549M	-$6.474M
Capital Expenditures		-$29.00K
Free Cash Flow		-$6.445M
YoY Change		157.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2022Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	dei	Entity File Number EntityFileNumber	000-55863
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses		usd
CY2022Q4	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2022Q4	rfl	Proceeds From Issuance Of Common Stock From Related Party ProceedsFromIssuanceOfCommonStockFromRelatedParty		usd
CY2022Q4	rfl	Payment Of Transaction Costs Incurred In Connection With Sale Of Common Stock PaymentOfTransactionCostsIncurredInConnectionWithSaleOfCommonStock		usd
CY2022Q4	dei	Entity Registrant Name EntityRegistrantName	RAFAEL HOLDINGS, INC.
CY2022Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-2296593
CY2021Q4	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments		usd
CY2022Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	520 Broad Street
CY2022Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Newark
CY2022Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2021Q4	rfl	Paymentof Note Payableinconnectionwithsale PaymentofNotePayableinconnectionwithsale		usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.22
CY2022Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07102
CY2021Q4	rfl	Transaction Costs Related To Sale TransactionCostsRelatedToSale		usd
CY2022Q4	dei	City Area Code CityAreaCode	(212)
CY2022Q4	dei	Local Phone Number LocalPhoneNumber	658-1450
CY2022Q4	dei	Trading Symbol TradingSymbol	RFL
CY2022Q4	dei	Security12b Title Security12bTitle	Class B common stock, par value $0.01 per share
CY2022Q4	dei	Document Type DocumentType	10-Q
CY2022Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q4	dei	Document Period End Date DocumentPeriodEndDate	2022-10-31
CY2022Q4	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q4	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q4	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22173000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26537000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	660000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	71014000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	36698000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	171000	usd
CY2022Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	140000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	242000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	197000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	135000	usd
CY2022Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	157000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	768000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4621000	usd
CY2022Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	40194000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	94921000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	108347000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1751000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1770000	usd
CY2022Q4	rfl	Investments Other Pharmaceuticals InvestmentsOtherPharmaceuticals	321000	usd
CY2022Q3	rfl	Investments Other Pharmaceuticals InvestmentsOtherPharmaceuticals	477000	usd
CY2022Q4	rfl	Investments Hedge Funds InvestmentsHedgeFunds	4637000	usd
CY2022Q3	rfl	Investments Hedge Funds InvestmentsHedgeFunds	4764000	usd
CY2022Q4	rfl	In Process Research And Development InProcessResearchAndDevelopment	1575000	usd
CY2022Q3	rfl	In Process Research And Development InProcessResearchAndDevelopment	1575000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1387000	usd
CY2022Q4	us-gaap	Assets Assets	103216000	usd
CY2022Q3	us-gaap	Assets Assets	118320000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1394000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	564000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1602000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1875000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	166000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3518000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	44000	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	69000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	15000000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3206000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	21026000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	44000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	88000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3250000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	21114000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	8000	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	8000	usd
CY2022Q4	rfl	Common Stock Value1 CommonStockValue1	237000	usd
CY2022Q3	rfl	Common Stock Value1 CommonStockValue1	237000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	263197000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	262023000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-163865000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165457000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	40000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-63000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	3757000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	3767000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	103374000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	100515000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-3408000	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	-3309000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	99966000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	97206000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	103216000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118320000	usd
CY2022Q4	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	43000	usd
CY2021Q4	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	44000	usd
CY2022Q4	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	27000	usd
CY2021Q4	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	27000	usd
CY2021Q4	rfl	Revenues Other Related Party RevenuesOtherRelatedParty	120000	usd
CY2022Q4	us-gaap	Revenues Revenues	70000	usd
CY2021Q4	us-gaap	Revenues Revenues	191000	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3109000	usd
CY2021Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12274000	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2081000	usd
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2153000	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22000	usd
CY2021Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19000	usd
CY2021Q4	rfl	Provision For Loss On Receivable Pursuant To Line Of Credit ProvisionForLossOnReceivablePursuantToLineOfCredit	25000000	usd
CY2021Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	10283000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-5142000	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-49538000	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	13000	usd
CY2022Q4	us-gaap	Interest Income Other InterestIncomeOther	208000	usd
CY2021Q4	us-gaap	Interest Income Other InterestIncomeOther	188000	usd
CY2022Q4	us-gaap	Impairment Of Investments ImpairmentOfInvestments	156000	usd
CY2021Q4	rfl	Impairment Of Cost Method Investment Rafael Pharmaceuticals ImpairmentOfCostMethodInvestmentRafaelPharmaceuticals	79141000	usd
CY2022Q4	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	15000	usd
CY2022Q4	rfl	Unrealized Gain On Investments Hedge Fund UnrealizedGainOnInvestmentsHedgeFund	127000	usd
CY2021Q4	rfl	Unrealized Gain On Investments Hedge Fund UnrealizedGainOnInvestmentsHedgeFund	-211000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5202000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-128293000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000	usd
CY2021Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-575000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-5207000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-128868000	usd
CY2022Q4	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-84000	usd
CY2021Q4	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-543000	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	6784000	usd
CY2022Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	6700000	usd
CY2021Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-543000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	1493000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-129411000	usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-99000	usd
CY2021Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-17387000	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1592000	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-112024000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	1493000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-129411000	usd
CY2022Q4	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	103000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	10000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-9000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	1586000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-129402000	usd
CY2022Q4	rfl	Comprehensive Loss Attributable To Noncontrolling Interests ComprehensiveLossAttributableToNoncontrollingInterests	-99000	usd
CY2021Q4	rfl	Comprehensive Loss Attributable To Noncontrolling Interests ComprehensiveLossAttributableToNoncontrollingInterests	36000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1685000	usd
CY2021Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-129438000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.22
CY2021Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-5.88
CY2022Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.29
CY2021Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.03
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.91
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23015443	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18948084	shares
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	97206000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	1493000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1180000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	6000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	103000	usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	99966000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	136704000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-129411000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7851000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	99170000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-6228000	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	4997000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	30000	usd
CY2021Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	9000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	113062000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	1493000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-129411000	usd
CY2022Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-6700000	usd
CY2021Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	543000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5207000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-128868000	usd
CY2022Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22000	usd
CY2021Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19000	usd
CY2022Q4	rfl	Gain Loss On Investments Hedge Fund GainLossOnInvestmentsHedgeFund	-127000	usd
CY2021Q4	rfl	Gain Loss On Investments Hedge Fund GainLossOnInvestmentsHedgeFund	211000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	15000	usd
CY2022Q4	us-gaap	Impairment Of Investments ImpairmentOfInvestments	156000	usd
CY2021Q4	rfl	Impairment Altira ImpairmentAltira	-79141000	usd
CY2021Q4	rfl	Provision For Loss On Receivable Pursuant To Line Of Credit ProvisionForLossOnReceivablePursuantToLineOfCredit	25000000	usd
CY2021Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	188000	usd
CY2021Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-575000	usd
CY2021Q4	rfl	Provision For Losses On Related Party Receivables ProvisionForLossesOnRelatedPartyReceivables	10283000	usd
CY2021Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	19000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	1180000	usd
CY2021Q4	us-gaap	Share Based Compensation ShareBasedCompensation	7851000	usd
CY2021Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	125000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	28000	usd
CY2021Q4	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	496000	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-566000	usd
CY2021Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-649000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	28000	usd
CY2021Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-54000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1017000	usd
CY2021Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	48000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	103000	usd
CY2021Q4	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-124000	usd
CY2022Q4	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	25000	usd
CY2021Q4	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	84000	usd
CY2021Q4	rfl	Increase Decrease In Due From Rafael Pharmaceuticals IncreaseDecreaseInDueFromRafaelPharmaceuticals	120000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-4000	usd
CY2021Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-33000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2128000	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6294000	usd
CY2022Q4	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-421000	usd
CY2021Q4	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-180000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2549000	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6474000	usd
CY2022Q4	rfl	Paymentfrominterestreceivable Paymentfrominterestreceivable	31000	usd
CY2021Q4	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	25000000	usd
CY2021Q4	rfl	Payment To Fund Rp Finance Line Of Credit PaymentToFundRPFinanceLineOfCredit	1875000	usd
CY2022Q4	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	57119000	usd
CY2022Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	22922000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-34228000	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-26875000	usd
CY2022Q4	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	49400000	usd
CY2022Q4	rfl	Payment Of Transaction Costs For Sale PaymentOfTransactionCostsForSale	1229000	usd
CY2021Q4	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	29000	usd
CY2022Q4	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	48171000	usd
CY2021Q4	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-29000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13943000	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26904000	usd
CY2021Q4	rfl	Proceeds From Issuance Of Common Stock From Related Party ProceedsFromIssuanceOfCommonStockFromRelatedParty	104167000	usd
CY2021Q4	rfl	Payment Of Transaction Costs Incurred In Connection With Sale Of Common Stock PaymentOfTransactionCostsIncurredInConnectionWithSaleOfCommonStock	6228000	usd
CY2022Q4	rfl	Common Shares Issued For Payment Of Purchase Price For Altira Equity CommonSharesIssuedForPaymentOfPurchasePriceForAltiraEquity	6000	usd
CY2021Q4	rfl	Common Shares Issued For Payment Of Purchase Price For Altira Equity CommonSharesIssuedForPaymentOfPurchasePriceForAltiraEquity	30000	usd
CY2022Q4	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-6000	usd
CY2021Q4	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	97909000	usd
CY2022Q4	rfl	Paymentof Note Payableinconnectionwithsale PaymentofNotePayableinconnectionwithsale	15000000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15006000	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	97909000	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-92000	usd
CY2021Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3704000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	64533000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26537000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12854000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22833000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77387000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22173000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72387000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	660000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	5000000	usd
CY2022Q4	rfl	Total Cash And Cash Equivalent And Restricted Cash Shown In Statement Of Cash Flows TotalCashAndCashEquivalentAndRestrictedCashShownInStatementOfCashFlows	22833000	usd
CY2021Q4	rfl	Total Cash And Cash Equivalent And Restricted Cash Shown In Statement Of Cash Flows TotalCashAndCashEquivalentAndRestrictedCashShownInStatementOfCashFlows	77387000	usd
CY2022Q4	rfl	Transaction Costs Related To Sale TransactionCostsRelatedToSale	43000	usd
CY2022Q4	rfl	Outstanding Capital Stock OutstandingCapitalStock	0.51	pure
CY2022Q4	rfl	Capital Stock CapitalStock	0.42	pure
CY2022Q4	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	22200000	usd
CY2022Q4	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	71000000	usd
CY2022Q4	rfl	Investments Hedge Funds InvestmentsHedgeFunds	4600000	usd
CY2022Q3	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	33000000	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	249000	usd
CY2022Q4	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	0	usd
CY2020Q3	us-gaap	Other Commitment OtherCommitment	5000000	usd
CY2022Q4	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentration of Credit Risk and Significant Customers </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company routinely assesses the financial strength of its customers. As a result, the Company believes that its accounts receivable credit risk exposure is limited. For the three months ended October 31, 2022, including revenue from discontinued operations, related parties represented 44% of the Company’s revenue, and as of October 31, 2022, one customer represented 67% of the Company’s accounts receivable balance. For the three months ended October 31, 2021, related parties represented 63% of the Company’s revenue, and as of October 31, 2021, two customers, one of which is a related party, represented 71% and 14% of the Company’s accounts receivable balance, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue	835000	usd
CY2022Q4	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	246000	usd
CY2021Q4	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	618000	usd
CY2021Q4	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	363000	usd
CY2022Q4	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-3000	usd
CY2022Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	1200000	usd
CY2022Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	1200000	usd
CY2021Q4	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	146000	usd
CY2019Q1	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	10000000	usd
CY2022Q4	rfl	Percentage Of Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent PercentageOfConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent	0.50	pure
CY2022Q4	us-gaap	Finance Lease Impairment Loss FinanceLeaseImpairmentLoss	17300000	usd
CY2022Q4	rfl	Shares Issuable Upon Exercise Of Warrants SharesIssuableUponExerciseOfWarrants		shares
CY2022Q4	us-gaap	Interest Expense Other InterestExpenseOther	87000	usd
CY2021Q4	us-gaap	Interest Expense Other InterestExpenseOther	397000	usd
CY2022Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-84000	usd
CY2022Q3	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	49400000	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	15000000	usd
CY2022Q4	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	33000000	usd
CY2022Q4	us-gaap	Other Minority Interests OtherMinorityInterests	79100000	usd
CY2022Q4	rfl	Interest Amount interestAmount	10400000	usd
CY2022Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	45437000	usd
CY2022Q3	us-gaap	Land Land	10412000	usd
CY2022Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1145000	usd
CY2022Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Other AssetsHeldForSaleNotPartOfDisposalGroupOther	205000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57199000	usd
CY2022Q3	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	17005000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	40194000	usd
CY2022Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current Other AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther	40194000	usd
CY2022Q3	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	40194000	usd
CY2022Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	15000000	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	0	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	150000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	0	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	1300000	usd
CY2021Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-543000	usd
CY2022Q4	us-gaap	Gain Loss On Disposition Of Real Estate Discontinued Operations GainLossOnDispositionOfRealEstateDiscontinuedOperations	6784000	usd
CY2022Q4	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	6700000	usd
CY2021Q4	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-543000	usd
CY2022Q4	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	6800000	usd
CY2022Q4	rfl	Gross Proceeds GrossProceeds	49400000	usd
CY2022Q4	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	40200000	usd
CY2020Q4	us-gaap	Other Commitment OtherCommitment	5000000	usd
CY2021Q2	us-gaap	Other Commitment OtherCommitment	10000000	usd
CY2021Q3	us-gaap	Other Commitment OtherCommitment	10000000	usd
CY2021Q3	us-gaap	Other Commitment OtherCommitment	5000000	usd
CY2022Q4	rfl	Cumulative Funds Description CumulativeFundsDescription	As of October 31, 2022, the Company has funded a cumulative total of $9.375 million in accordance with its 37.5% ownership interests in RP Finance.
CY2022Q4	rfl	Issued And Outstanding Ordinary Shares Percentage IssuedAndOutstandingOrdinarySharesPercentage	0.84	pure
CY2021Q3	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.15	pure
CY2021Q4	us-gaap	Shares Issued SharesIssued	15975000	shares
CY2021Q4	rfl	Purchase Price PurchasePrice	0.1878	usd
CY2021Q4	rfl	Amount Of Aggregate Purchase Price AmountOfAggregatePurchasePrice	3000000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Other Carrying Amount RedeemableNoncontrollingInterestEquityOtherCarryingAmount	8000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	15000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	242000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	197000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	135000	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	157000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.22
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	54809000	usd
CY2022Q4	rfl	Availableforsale Securities Us Treasury Bills AvailableforsaleSecuritiesUSTreasuryBills	16205000	usd
CY2022Q4	rfl	Hedge Funds HedgeFunds	4637000	usd
CY2022Q4	rfl	Available For Sale Securities Total AvailableForSaleSecuritiesTotal	75651000	usd
CY2022Q3	us-gaap	Assets Designated To Closed Block Equity Securities Available For Sale At Fair Value AssetsDesignatedToClosedBlockEquitySecuritiesAvailableForSaleAtFairValue	36698000	usd
CY2022Q3	rfl	Hedge Funds HedgeFunds	4764000	usd
CY2022Q3	rfl	Available For Sale Securities Total AvailableForSaleSecuritiesTotal	41462000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	4764000	usd
CY2021Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	5268000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-127000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	211000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	4637000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	5479000	usd
CY2022Q4	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	300000	usd
CY2022Q4	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	156	usd
CY2021Q4	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	254000	usd
CY2022Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	196000	usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	123000	usd
CY2022Q3	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	158000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-5.88
CY2022Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.29
CY2021Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.03
CY2022Q4	us-gaap	Earnings Per Share Basic Undistributed EarningsPerShareBasicUndistributed	0.07
CY2021Q4	us-gaap	Earnings Per Share Basic Undistributed EarningsPerShareBasicUndistributed	-5.91
CY2022Q2	us-gaap	Employee Stock Ownership Plan Esop Terms Of Repurchase Obligation EmployeeStockOwnershipPlanESOPTermsOfRepurchaseObligation	On June 22, 2022, the Company entered into a Stock Purchase Agreement (the “I9 SPA”) with I9 Plus, LLC. On July 6, 2022, pursuant to the I9 SPA, the Company sold 3,225,806 shares of the Company’s Class B common stock to I9 Plus, LLC at a price per share of $1.86 and an aggregate sale price of $6 million.
CY2022Q4	rfl	Stock Options Excluded From Anti Diluted StockOptionsExcludedFromAntiDiluted	1021277	shares
CY2021Q4	rfl	Stock Options Excluded From Anti Diluted StockOptionsExcludedFromAntiDiluted	960554	shares
CY2022Q4	rfl	Shares Issuable Upon Vesting Of Restricted Stock SharesIssuableUponVestingOfRestrictedStock	1461934	shares
CY2021Q4	rfl	Shares Issuable Upon Vesting Of Restricted Stock SharesIssuableUponVestingOfRestrictedStock	1004265	shares
CY2021Q4	rfl	Shares Issuable Upon Exercise Of Warrants SharesIssuableUponExerciseOfWarrants	26189	shares
CY2022Q4	rfl	Total Total	2483211	shares
CY2021Q4	rfl	Total Total	1991008	shares
CY2022Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5207000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-128868000	usd
CY2022Q4	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable	-99000	usd
CY2021Q4	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable	-17387000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5108000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-111481000	usd
CY2022Q4	rfl	Numerator For Discontinued Operations NumeratorForDiscontinuedOperations	6700000	usd
CY2021Q4	rfl	Numerator For Discontinued Operations NumeratorForDiscontinuedOperations	-543000	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1592000	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-112024000	usd
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23015443	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18948084	shares
CY2021Q3	us-gaap	Notes Payable NotesPayable	15000000	usd
CY2022Q4	us-gaap	Long Term Debt Description LongTermDebtDescription	The Note Payable bore interest at a rate per annum equal to seven and one-quarter percent (7.25%) from July 9, 2021 through July 31, 2021 and thereafter at an interest rate per annum equal to the 30-day LIBOR Rate, as published in The Wall Street Journal, plus 6.90% per annum, but in no event less than seven and one-quarter percent (7.25%) per annum. The Note Payable was due on August 1, 2022, subject to the Company’s option to extend the maturity date until August 1, 2023 for a fee equal to three-quarters of one percent (0.75%) of the Note Payable.
CY2022Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-11-01
CY2022Q3	us-gaap	Line Of Credit Facility Frequency Of Payment And Payment Terms LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms	$37,500
CY2022Q3	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	15000000	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	87000000	usd
CY2022Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	87000	usd
CY2021Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	271000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	347000	usd
CY2022Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	usd
CY2021Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	125000	usd
CY2022Q4	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	68000	usd
CY2021Q4	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	75000	usd
CY2022Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	44000	usd
CY2021Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	75000	usd
CY2022Q4	us-gaap	Area Of Land AreaOfLand	80000	sqft
CY2022Q4	rfl	Rent And Parking Expense RentAndParkingExpense	129000	usd
CY2022Q4	rfl	Rent And Parking Expenses RentAndParkingExpenses	102000	usd
CY2021Q4	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	720000	usd
CY2022Q4	rfl	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P4Y5M19D
CY2022Q4	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	The Company leased space to related parties (including IDT Corporation - see above) which represented approximately 44% and 63% for the three months ended October 31, 2022 and 2021, respectively. The portion of related party rental income pertaining to the 520 Property has been classified in discontinued operations on the consolidated statements of operations and comprehensive income (loss) for the three months ended October 31, 2022 and 2021.
CY2022Q4	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	0	usd
CY2021Q4	us-gaap	Gain Loss On Fair Value Hedges Recognized In Earnings GainLossOnFairValueHedgesRecognizedInEarnings	575000	usd
CY2020Q4	rfl	Warrants Percentage WarrantsPercentage	0.20	pure
CY2020Q4	rfl	Exercise Price ExercisePrice	22.91
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.91
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18948084	shares
CY2022Q4	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	5000	usd
CY2021Q4	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	5200000	usd
CY2022Q4	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	0	usd
CY2021Q4	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	128800000	usd
CY2022Q4	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2022Q4	rfl	Sale Of Building Description SaleOfBuildingDescription	The Real Estate segment consists of the Company’s real estate holdings, comprised of a portion of a commercial building in Israel.
CY2022Q4	us-gaap	Revenues Revenues	70000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-5142000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5202000	usd
CY2021Q4	us-gaap	Revenues Revenues	191000	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-49538000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-128293000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1021277	shares
CY2022Q4	rfl	Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePrice	12.11
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M19D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	594607	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.69
CY2021Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-5.88
CY2022Q4	rfl	Revenue From Tenants RevenueFromTenants	0.22	pure
CY2021Q4	rfl	Revenue From Tenants RevenueFromTenants	0.07	pure
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23015443	shares
CY2021Q4	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss		usd
CY2021Q4	us-gaap	Impairment Of Investments ImpairmentOfInvestments		usd
CY2022Q4	rfl	Impairment Altira ImpairmentAltira		usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1751000	usd
CY2022Q4	rfl	Total Asset TotalAsset	103216000	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	1770000	usd
CY2022Q3	rfl	Total Asset TotalAsset	118320000	usd
CY2021Q3	rfl	Restricted Stock Units Description RestrictedStockUnitsDescription	the Company issued 2,833,425 shares of Class B common stock (the “Institutional Shares”), par value $0.01 per share, to the Institutional Investors, at a purchase price equal to $35.00 per share, for aggregate gross proceeds of approximately $99.2 million, before deducting placement agent fees and other offering expenses.
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1021277	shares
CY2022Q3	rfl	Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePrice	12.11
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y9M18D
CY2022Q4	rfl	Provision For Loss On Receivable Pursuant To Line Of Credit ProvisionForLossOnReceivablePursuantToLineOfCredit		usd
CY2022Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2022Q4	rfl	Provision For Losses On Related Party Receivables ProvisionForLossesOnRelatedPartyReceivables		usd
CY2022Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2022Q4	rfl	Increase Decrease In Due From Rafael Pharmaceuticals IncreaseDecreaseInDueFromRafaelPharmaceuticals		usd
CY2021Q4	rfl	Paymentfrominterestreceivable Paymentfrominterestreceivable		usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	10000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M4D
CY2022Q1	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	33360	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	151000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	986835	shares
CY2022Q1	rfl	Restricted Shares Vested Percentage RestrictedSharesVestedPercentage	0.24	pure
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	452130	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1507373	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.22
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	45439	shares
CY2022Q4	rfl	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionVestedInPeriodWeightedAverageGrantDateFairValue	4.04
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1461934	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.22
CY2022Q4	rfl	Forfeiture Of Rs Us Within Selling General And Administratives ForfeitureOfRSUsWithinSellingGeneralAndAdministratives	1083000	usd
CY2021Q4	rfl	Forfeiture Of Rs Us Within Selling General And Administratives ForfeitureOfRSUsWithinSellingGeneralAndAdministratives	7668000	usd
CY2022Q4	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	97000	usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	183000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	1180000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	7851000	usd
CY2022Q4	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2022Q4	rfl	Payment To Fund Rp Finance Line Of Credit PaymentToFundRPFinanceLineOfCredit		usd
CY2021Q4	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt		usd
CY2021Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities		usd
CY2021Q4	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2021Q4	rfl	Payment Of Transaction Costs For Sale PaymentOfTransactionCostsForSale		usd
CY2022	rfl	Lease Expiration Dates LeaseExpirationDates	The Company is the lessor of the Israeli property which is leased to tenants under net operating leases with a term expiration date within 2025.
CY2022Q4	rfl	Comprehensive Income Loss Net Of Tax Attributable To Noncontrolling Interests ComprehensiveIncomeLossNetOfTaxAttributableToNoncontrollingInterests	100000	usd
CY2021Q4	rfl	Comprehensive Income Loss Net Of Tax Attributable To Noncontrolling Interests ComprehensiveIncomeLossNetOfTaxAttributableToNoncontrollingInterests	100000	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	57000	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	77000	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	78000	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	212000	usd
CY2022Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent		usd
CY2022Q4	us-gaap	Interest Expense InterestExpense		usd
CY2021Q4	us-gaap	Impairment Of Investments ImpairmentOfInvestments		usd
CY2022Q4	rfl	Impairment Of Cost Method Investment Rafael Pharmaceuticals ImpairmentOfCostMethodInvestmentRafaelPharmaceuticals		usd
CY2021Q4	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
CY2021Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.03
CY2022Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.29
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18948084	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23015443	shares
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.22
CY2021Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-5.88
CY2021Q4	rfl	Discontinued Operation Income Loss From Discontinued Operations Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.03
CY2022Q4	rfl	Discontinued Operation Income Loss From Discontinued Operations Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.29
CY2022Q4	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	0.07
CY2021Q4	us-gaap	Basic Earnings Per Share Adjustment Pro Forma BasicEarningsPerShareAdjustmentProForma	-5.91
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q4	rfl	Weighted Average Remaining Contractual Termin Years Granted WeightedAverageRemainingContractualTerminYearsGranted
CY2022Q4	rfl	Aggregate Intrinsic Value Outstanding Granted AggregateIntrinsicValueOutstandingGranted		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q4	rfl	Weighted Average Remaining Contractual Termin Years Cancelled Forfeited WeightedAverageRemainingContractualTerminYearsCancelledForfeited
CY2022Q4	rfl	Aggregate Intrinsic Value Cancelled Forfeited AggregateIntrinsicValueCancelledForfeited		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2022Q4	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--07-31
CY2022Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001713863

Files In Submission

Name	View Source	Status
0001213900-22-079292-index-headers.html	Edgar Link	pending
0001213900-22-079292-index.html	Edgar Link	pending
0001213900-22-079292.txt	Edgar Link	pending
0001213900-22-079292-xbrl.zip	Edgar Link	pending
f10q1022ex31-1_rafaelhold.htm	Edgar Link	pending
f10q1022ex31-2_rafaelhold.htm	Edgar Link	pending
f10q1022ex32-1_rafaelhold.htm	Edgar Link	pending
f10q1022ex32-2_rafaelhold.htm	Edgar Link	pending
f10q1022_rafaelhold.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
f10q1022_rafaelhold_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rfl-20221031.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rfl-20221031_cal.xml	Edgar Link	unprocessable
rfl-20221031_def.xml	Edgar Link	unprocessable
rfl-20221031_pre.xml	Edgar Link	unprocessable
rfl-20221031_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RFL
Rafael Holdings Inc Stock $rfl

2022 Q4 Form 10-Q Financial Statement

#000121390022079292 Filed on December 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RFL Rafael Holdings Inc Stock $rfl

2022 Q4 Form 10-Q Financial Statement

#000121390022079292 Filed on December 13, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RFL
Rafael Holdings Inc Stock $rfl